Related Experiment Videos
Biphasic effects of MIF-1 and Tyr-MIF-1 on apomorphine-induced stereotypy in rats
Abstract:
The effects of several doses of MIF-1 and Tyr-MIF-1 (0.2, 0.5, 1.0 and 5.0 mg/kg, SC) on the stereotypic behavior induced by various doses (0.08, 0.2, 0.5, 1.0 and 2.0 mg/kg, SC) of apomorphine (APO) were tested in rats. MIF-1 increased the stereotypic behavior induced by 0.5 and 1.0 mg/kg of APO, but decreased the stereotypic behavior induced by 2.0 mg/kg of APO. Tyr-MIF-1 showed a biphasic effect similar to that exerted by MIF-1. The results suggest that the type of response to MIF-1 and Tyr-MIF-1 after APO is influenced by the activity of central dopaminergic neurons.
Insights
MIF-1 and Tyr-MIF-1 peptides modulate apomorphine-induced stereotypic behavior in rats. Their effects depend on the apomorphine dose, suggesting a link to central dopaminergic neuron activity.
Area of Science:
- Neuropharmacology
- Behavioral Neuroscience
Background:
- Stereotypic behaviors are repetitive, invariant motor actions.
- Apomorphine (APO) is a dopamine receptor agonist that induces stereotypic behavior.
- MIF-1 and Tyr-MIF-1 are peptides with potential neuromodulatory roles.
Purpose of the Study:
- To investigate the effects of MIF-1 and Tyr-MIF-1 on apomorphine-induced stereotypic behavior in rats.
- To determine if the effects of MIF-1 and Tyr-MIF-1 are dose-dependent and influenced by apomorphine dosage.
Main Methods:
- Rats were administered various doses of apomorphine (0.08–2.0 mg/kg).
- MIF-1 and Tyr-MIF-1 were administered at doses of 0.2, 0.5, 1.0, and 5.0 mg/kg.
- Stereotypic behavior was quantified and analyzed in response to combined treatments.
Main Results:
- MIF-1 increased apomorphine-induced stereotypic behavior at 0.5 and 1.0 mg/kg APO doses.
- MIF-1 decreased apomorphine-induced stereotypic behavior at a 2.0 mg/kg APO dose.
- Tyr-MIF-1 exhibited a biphasic effect similar to MIF-1.
Conclusions:
- The effects of MIF-1 and Tyr-MIF-1 on apomorphine-induced stereotypic behavior are dose-dependent.
- These peptide effects appear to be modulated by the activity level of central dopaminergic neurons.